Introducing the results related to the programs that AMED's supports R&D
Achievements
What's New
-
2021.3.4First wearable device can monitor jaundice-causing bilirubin and vitals in newborns
-
2021.2.3Development of a method for producing conjunctival epithelium from iPS cells - Novel technology to accelerate drug discovery and regenerative medicine for eye diseases -
-
2021.2.3Small-molecule anti-HIV active compounds targeting HIV-1 capsid protein - Development of novel therapeutic agents for drug-resistant viruses -
-
2021.1.29Health tips in the mouth - First large-scale oral microbiome analysis in Japan -
-
2021.1.29Development of the world's first quantum sensors to detect “oxidative stress” - Preemptive medicine for preventing lifestyle-related diseases and inflammation using optical imaging and MRI -
-
2021.1.27Development of a culture medium for convenient and efficient proliferation of human iPS cells - Cost reduction in regenerative medicine -
-
2021.1.27Hybrid compounds of small molecule CD4 mimics and polyethylene glycol units as HIV entry inhibitors - Combined therapy with an antibody for radical care -
-
2021.1.26Development of an AI model for facial identification of patients with cognitive decline
-
2021.1.20Discovery of a causative protein for thalidomide teratogenicity - Mechanism of the adverse effects of thalidomide -
-
2021.1.15Elucidation of the protein-drug complex structure of the hERG channel responsible for adverse effects - Usefulness of cryo-electron microscopy in avoiding serious adverse effects -